Gritstone Oncology, developing cancer immunotherapies to fight multiple cancer types
Gritstone Oncology advances into phase 2 expansion cohorts for its personalized neoantigen immunotherapy GRANITE and its off-the-shelf neoantigen immunotherapy SLATE
...
Nov 03